126 related articles for article (PubMed ID: 31635311)
1. Anti-Cancer Effects of Synergistic Drug-Bacterium Combinations on Induced Breast Cancer in BALB/c Mice.
Subramaniam M; Arshad NM; Mun KS; Malagobadan S; Awang K; Nagoor NH
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31635311
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells.
Subramaniam M; Liew SK; In L; Awang K; Ahmed N; Nagoor NH
Drug Des Devel Ther; 2018; 12():1053-1063. PubMed ID: 29750018
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring AFP-receptors.
Arshad NM; In LL; Soh TL; Azmi MN; Ibrahim H; Awang K; Dudich E; Tatulov E; Nagoor NH
Oncotarget; 2015 Jun; 6(18):16151-67. PubMed ID: 26158863
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative, apoptotic induction, and anti-migration effects of hemi-synthetic 1'
Liew SK; Azmi MN; In L; Awang K; Nagoor NH
Drug Des Devel Ther; 2017; 11():2763-2776. PubMed ID: 29075101
[TBL] [Abstract][Full Text] [Related]
5. 1'-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations.
In LL; Arshad NM; Ibrahim H; Azmi MN; Awang K; Nagoor NH
BMC Complement Altern Med; 2012 Oct; 12():179. PubMed ID: 23043547
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity.
Xu Y; Han X; Li Y; Min H; Zhao X; Zhang Y; Qi Y; Shi J; Qi S; Bao Y; Nie G
ACS Nano; 2019 Nov; 13(11):13445-13455. PubMed ID: 31670945
[TBL] [Abstract][Full Text] [Related]
7. Bromelain Enhances the Anti-tumor Effects of Cisplatin on 4T1 Breast Tumor Model In Vivo.
Mohamad NE; Abu N; Yeap SK; Alitheen NB
Integr Cancer Ther; 2019; 18():1534735419880258. PubMed ID: 31752555
[No Abstract] [Full Text] [Related]
8. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
9. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of benzhydrol derivatives based on 1'-acetoxychavicol acetate (ACA) and their inhibitory activities on multiple myeloma cell growth via inactivation of the NF-κB pathway.
Misawa T; Dodo K; Ishikawa M; Hashimoto Y; Sagawa M; Kizaki M; Aoyama H
Bioorg Med Chem; 2015 May; 23(9):2241-6. PubMed ID: 25801158
[TBL] [Abstract][Full Text] [Related]
11. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
Liu J; Chen X; Ward T; Pegram M; Shen K
Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
[TBL] [Abstract][Full Text] [Related]
12. Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.
Islam SS; Al-Sharif I; Sultan A; Al-Mazrou A; Remmal A; Aboussekhra A
Mol Carcinog; 2018 Mar; 57(3):333-346. PubMed ID: 29073729
[TBL] [Abstract][Full Text] [Related]
13. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
14. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Kalafut J; Okla K; Halasa M; Rivero-Muller A; Stepulak A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357442
[TBL] [Abstract][Full Text] [Related]
15. Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A.
Izgi K; Iskender B; Sakalar C; Arslanhan A; Yuksek EH; Hizar E; Canatan H
Anticancer Agents Med Chem; 2017; 17(3):404-414. PubMed ID: 27039926
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products.
Ichikawa H; Takada Y; Murakami A; Aggarwal BB
J Immunol; 2005 Jun; 174(11):7383-92. PubMed ID: 15905586
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of water-soluble complex of 1'-acetoxychavicol acetate with highly branched β-1,3-glucan on contact dermatitis.
Li J; Aizawa Y; Hiramoto K; Kasahara E; Tsuruta D; Suzuki T; Ikeda A; Azuma H; Nagasaki T
Biomed Pharmacother; 2015 Feb; 69():201-7. PubMed ID: 25661358
[TBL] [Abstract][Full Text] [Related]
18. A novel CRAd in combination with cisplatin enhanced the antitumor efficacy in ovarian cancer.
Zhang B; Liu Y; Zhang P; Wei Y; Yin X; Zheng J
Int J Gynecol Cancer; 2011 Dec; 21(9):1540-6. PubMed ID: 22080895
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile toxin B recombinant protein inhibits tumor growth and induces apoptosis through inhibiting Bcl-2 expression, triggering inflammatory responses and activating C-erbB-2 and Cox-2 expression in breast cancer mouse model.
Zhang Y; Li Y; Li H; Chen W; Liu W
Biomed Pharmacother; 2018 May; 101():391-398. PubMed ID: 29501042
[TBL] [Abstract][Full Text] [Related]
20. The microneedles carrying cisplatin and IR820 to perform synergistic chemo-photodynamic therapy against breast cancer.
Fu JJ; Li CW; Liu Y; Chen MY; Zhang Q; Yu XY; Wu B; Li JX; Du LR; Dang YY; Wu D; Wei MY; Lin ZQ; Lei XP
J Nanobiotechnology; 2020 Oct; 18(1):146. PubMed ID: 33076924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
